Immune checkpoint therapyIntervention2 papersAnimals1In silico1LatestNature Communications·Jul 23Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8⁺ T cell activation and limit responsiveness to immunotherapy in miceExperiments in micePancreatic ductal adenocarcinomaPaperJournal of Oncology·Feb 28Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular CarcinomaComputational studyHepatocellular carcinomaPaper
Nature Communications·Jul 23Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8⁺ T cell activation and limit responsiveness to immunotherapy in miceExperiments in micePancreatic ductal adenocarcinomaPaper
Journal of Oncology·Feb 28Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular CarcinomaComputational studyHepatocellular carcinomaPaper